• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of webinars, teleconferences, and other meetings conducted with Center for Disease Control (CDC), Substance Abuse and Mental Health Services Administration (SAMHSA), and other federal partners in the month

Dictionary: The primary objectives of stakeholder meetings are to share information so that the mission of the Center for Tobacco Products is recognized, understood and supported to the maximum extent possible.

Information is current as of March 31, 2014

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A1
Nov 2013N/A7
Dec 2013N/A3
Jan 2014N/A7
Feb 2014N/A4
Mar 2014N/A5
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 27

Total number of webinars, teleconferences, and other meetings conducted with State, Territorial, Local, and Tribal tobacco control programs and other non-federal government partners and stakeholders in the month

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A2
Nov 2013N/A2
Dec 2013N/A0
Jan 2014N/A0
Feb 2014N/A0
Mar 2014N/A2
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 6

Total number of webinars, teleconferences, and other meetings conducted with non-governmental stakeholders in the month

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetNumber
Oct 2013N/A9
Nov 2013N/A4
Dec 2013N/A7
Jan 2014N/A3
Feb 2014N/A1
Mar 2014N/A5
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 29

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.